An email has come to light that exposes an even greater level of evil within the Biden regime than was previously believed.
The short of it is that the Food and Drug Administration (FDA) issued a recommendation that underage children take puberty blockers for LGBT transitions, even though the agency knew full well that the drugs “increased risk of depression and suicidality” in minors.
Officially, the Biden regime does not even try to hide its support for minors taking LGBT pharmaceuticals in order to “become themselves.” Their claim, though, is that these drugs are safe for children, which we now know to be untrue.
Not only is it untrue that puberty blockers are extremely dangerous for kids, but the FDA under Biden knew this when it issued its recommendation in support of them.
Shannon Sullivan, a “Clinical Team Leader” in the Division of General Endocrinology at the FDA, admitted this in a now-unearthed email, dated Jan. 25, 2022, to fellow FDA employee Theresa Kehoe.
Sullivan explained to Kehoe in the email that a safety review on the GnRH (gonadotropin-releasing hormone) agonist class of puberty blockers, which prevent the natural release of testosterone and estrogen in developing children, had been conducted in 2016 and 2017. The review found that this particular class of puberty-blocking drugs causes a host of serious health problems both in children and adults.
“The complaints were extensive and variable, and included fibromyalgia type symptoms, infertility, PCOS, and weight gain, among others,” Sullivan wrote about the long-term effects of GnRH agonists in adults with histories of this type of drug use.
Since the review Sullivan referenced focused primarily on suicidal ideation, depression, seizures and bone health, she would go on to reveal that the effects of puberty blockers in young children are even worse.
“We did find increased risk of depression and suicidality, as well as increased seizure risk and we issued SLCs to the entire class for these AEs (added to W&P in 2017).”
Just one paragraph later, Sullivan reiterated the fact that puberty blockers are profoundly dangerous for children, but proceeds to recommend them anyway.
“… there is definitely a need for these drugs to be approved for gender transition,” Sullivan wrote, adding that one of the many reasons for this is that puberty blockers “are typically not covered by insurance and are expensive out of pocket.”
In other words, Sullivan’s view seems to be that puberty blockers are admittedly dangerous but pre-pubescent children should definitely still get them with full approval from the FDA.
Hellbound and Down 